Clinical Emergencies Flashcards
what conditions come under acute coronary syndrome
STEMI
NSTEMI
Unstable angina
Initial investigations for someone with suspected STEMI/NSTEMI
ECG
Bloods: FBC, U+E, Troponin, (glucose + lipids)
CXR - but don’t delay management
BP on both arms
Initial management of STEMI
300mg of aspirin if not already given
180mg ticagrelor
5 - 10mg IV morphine + 10mg IV metoclopramide (can repeat morphine after 5 mins if necessary)
Can give oxygen if breathless or sats <95%
Can give bisoprolol if no heart failure, asthma/COPD or cardiogenic shock
Reperfusion therapy in STEMI
- Primary PCI - if less than 12h from symptom start + can be delivered within 2hrs of medical contact; can sometimes be given in 24h if evidence of ongoing ischaemia; also give injectable anticoagulant e.g. bivalirudin
- Thrombolysis with IV tenecteplase (tissue plasminogen activator) If PCI not available. Ideally within 30mins of admission; can be transferred for rescue PCI
- Fondaparinux if presenting >12h after symptom onset
Contraindications for thrombolysis
previous intracranial haemorrhage known bleeding disorder cerebral malignancy recent major trauma/surgery/head injury (3w) recent ischaemic stroke (6m)
relative CI: anticoagulant therapy, pregnancy, advanced liver disease
ECG STEMI findings
ST Elevation in 2 or more consecutive leads
new left bundle branch block
recipricol changes: deep ST depression
ECG NSTEMI findings
ST depression
Flat or inverted T waves
normal
Management of NSTEMI
Antiplatelets: aspirin - 300mg then 75mg OD + ticagrelor - 180mg then 90mg BD
Anticoagulation: Fondaparinux until discharge: 2.5mg OD
Analgesia: morphine 5-10mg IV + 10mg IV metoclopramide
Nitrates (PO or IV)
Beta-blockers (2.5mg bisoprolol), ACE-i, statins (80mg atorvastatin)
Address modifiable risk factors: smoking, hypertension, hyperlipidaemia, diabetes
How can you stratify patients with acute coronary syndrome and why is this important
GRACE score
- history of unstable angina, >70, general co-morbidities e.g. diabetes, previous MI
High risk patients may need coronary angiography –> coronary stenting or CABG
Causes of pulmonary oedema
Cardiovascular: LV failure post MI, valvular heart disease, arrythmias
Acute respiratory distress syndrome
Fluid overload
differential diagnoses for pulmonary oedema
asthma/COPD
pulmonary fibrosis: bi-basal crepitation
Pneumonia
signs/symptoms of pulmonary oedema
general observation: distressed, pale, sweaty, leaning forward
observations: increased pulse + resp rate (+ low O2 sats)
chest exam: increased JVP, wheeze, triple/gallop rhythm, crepitations
investigations for suspected pulmonary oedema
Bedside: ECG, glucose (SOB could be a sign of DKA)
Bloods: U+E, troponin, BNP, ABG
Imaging: CXR, consider echo
findings on CXR for pulmonary oedema
A - alveolar oedema B - kerley B lines C - cardiomegaly D - dilated upper lobe vessels E - pleural effusions (blunting of costophrenic angles)
findings on ECG for pulmonary oedema
MI, dysarrythmia
initial management of pulmonary oedema
oxygen if sats are low
IV diamorphine: 1.25mg - 5mg
IV Furosemide: 40-80mg
GTN/IV nitrate if BP>90/100
can repeat dose of furosemide
consider CPAP
management of pulmonary oedema once patient is stable
daily weights: -0,5kg/day
oral furosemide
consider addition of a thiazide e.g. bendroflumethiazide
consider ACE-i, beta-blockers and spironolactone
causes of cardiogenic shock
Cardiac: MI, arrythmias, myocarditis, aortic dissection
respiratory: PE, tension pneumothorax
management of cardiogenic shock
oxygen
diamorphine: IV 1.25 - 5MG
close monitoring
treat underlying cause
what is cardiac tamponade
increase in pericardial fluid increases intrapericardial pressure making it hard for the heart to fill –> heart stops pumping
causes of cardiac tamponade
signs of cardiac tamponade
management of cardiac tamponade
trauma, lung/breast cancer, pericarditis, MI
Beck’s triad: low BP, high JVP and muffled heart sounds
Also: pulsus paradoxus - pulse fades on inspiration
Get a senior at the bedside
investigations for suspected asthma
Bedside: PEF (if not too ill), BM (if suspecting DKA)
Bloods: ABG, FBC, U+E
Imaging: rule out pneumothorax, infection
Features of a severe asthma attack
Unable to complete sentences in one breath
RR>25, HR>110
PEF 33-50%
Features of life threatening asthma attack
general observation: exhaustion, confusion, coma
examination: silent chest, feeble respiratory effort, cyanosis
Bedside tests/observations: hypotension, arrythmia, PEF >33%, Sats <92%
ABG: normal/high PCO2 (>4.6); PO2 <8
Immediate management of asthma attack
oxygen
5mg nebulised salbutamol
30mg PO prednisolone (40mg if severe)
Reassess every 15 mins
- Add 0.5mg/6h ipratropium bromide if not responding or severe asthma
- Repeat salbutamol every 15-30m
- monitor ECG
- consider single dose IV magnesium sulfate 1.2 -2g
- ESCALATE
Continued management of asthma attack
If not improving after initial management
- refer to ICU for ventilatory support + aminophylline/ IV salbutamol
If improving
- continue nebulised salbutamol +/- ipratropium bromide every 4-6h
- 40-50mg prednisolone for 5-7 days
- monitor PEF and oxygen sats
- consider discharge if PEF > 75% 1h after initial treatment
otherwise discharge if
- stable on discharge medication for 24hrs
- check inhaler technique + that they’re on right medication (e.g. inhaled and oral steroids)
- written management plan
- GP appt within 2 days; resp clinic appt within 4weeks
investigations for COPD
Bedside: sputum culture, ECG
Bloods: FBC, U+E, CRP, blood cultures
Imaging: CXR
ethics surrounding advanced COPD
autonomy: what does the patient actually want? Speak to patient early
NM: doing harm by invasive ventilation? - difficult to wean off, ventilation associated pneumonia and pneumothoraces
management of acute COPD
nebulised salbutamol/ipratropium bromide (5mg/4h 0.5mg/6h)
Oxygen: venturi mask 24-28% oxygen; 88-92%
Steroids: 200mg IV hydrocortisone + oral 3omg prednisolone (continue for 7 - 14d)
Antibiotics: (evidence of infection) 500mg amoxicillin TD (or clarythromycin)
If no response
- consider IV aminophilline, NIPPV, intubation and ventilation
causes of pneumothorax
can be spontaneous, esp. in young thin men
trauma: inc. iatrogenic e.g. ventilation
chronic lung disease
infection
carcinoma
connective tissue disorders e.g. marfan
signs and symptoms of pneumothorax
pleuritic chest pain + dyspnoea
reduced chest expansion, hyperresonant, diminished breath sounds on affected side,
tension pneumothorax: trachea deviated away from affected side; respiratory distress, tachycardia, hypotension, distended neck veins
management of pneumothorax
Can discharge if its a primary pneumothorax, less than 2cm on CXR and no dyspnoea
Otherwise: Aspiration/insert chest drain
Tension pneumothorax: insert large bore needle + syringe with 0.9% saline into 2nd IC space, mid clavicular line; then request CXR, insert a chest drain
Most common organisms that cause pneumonia
Strep. pneumonia
Also: haemophilus influenzae, mycoplasma influenzae, influenza virus
ICU: staph. aureus
COPD/HAP: gram negative bacilli e.g. psuedomomas
Investigations for pneumonia
The usual plus:
sputum cultures
viral throat swabs (e.g. COVID)
How to calculate severity of pneumonia
CURB-65
- confusion (<8 on AMT)
- urea > 7mmol
- RR > 30
- BP <90/60
- Age >65
0-1: home
2: hospital
3+: severe pneumonia, consider ICU
management of pneumonia
oxygen
treat hypotension with IV fluids if requires
antibiotics: amoxicillin (5 days); co-amoxiclav if severe
analgesia for chest pain
Risk factors for PE
malignancy surgery (esp, pelvic + lower limb) immobility; active inflammation (infection, IBD) pregnancy, COCP, HRT Previous VTE
signs and symptoms of PE
acute dyspnoea, pleuritic chest pain, haemoptysis and syncope
hypotension, tachycardia, gallop rhythm, increased JVP, right ventricular heave, pleural rub, tachypnoea, cyanosis, AF
investigations for PE
Bedside: ECG - might show sinus tachycardia, RBBB, AF, right ventricular strain
Bloods: U+E, ABG, FBC, clotting
Imaging:
- CXR: rule out pneumonia, COVID etc.; may show wedged shaped infarction and small pleural effusions
- CTPA (ventilation perfusion scan if possible)
Management of PE
15L oxygen if hypoxic
IV morphine 5-10mg + antiemetic if distressed/in pain
IV LMWH/fondaparinux
500ml IV fluid bolus if hypotensive
consider thrombolysis with IV alteplase bolus if still haemodynamically unstable
initiate long term anticoagulation: DOAC or warfarin 3 - 6+ months
causes of upper GI bleeds
peptic ulcer disease gastroduodenal erosions oesophagitis MW tear varices
What are PRISMA guidelines
preferred reporting terms for systematic reviews and meta analyses
guidelines systematic reviews should follow such as clearly defining inclusion and exclusion criteria
what is a forest plot
a plot used in meta-analyses that show the effect/outcome of each study and the overall outcome
what do the lines on a forest plot represent
what happens if the mean diamond crosses the line of null effect
confidence interval
no significant difference between the treatment of interest and the control
what is a systematic review
a review of the literature regarding a research question of interest
what are the pros and cons of an RCT
pros: randomisation could reduce systemic bias by distributing confounding factors, prospective design can demonstrate temporality + causality
cons: expensive (may be funded by bodies with vested interest), time consuming, ethical concerns, requires large numbers of people